M27.1 identifies a central giant cell granuloma — a non-neoplastic, inflammatory lesion arising within the jaw bone (mandible or maxilla), distinguished from the peripheral variant, which involves the gingival soft tissue.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- Other
Documentation tips
What should appear in the chart to support M27.1.
Source · Editorial brief grounded in 5 cited references ↓
- Specify 'central' location explicitly — documentation must distinguish intraosseous (central) from gingival (peripheral) to justify M27.1 over K06.8.
- Record which jaw (mandible or maxilla) and laterality (right, left, or crossing midline) for surgical planning, even though M27.1 has no laterality subcode.
- Include imaging findings (panoramic radiograph, CBCT, or CT) describing the expansile lucent lesion, cortical thinning, or root resorption that confirm an intraosseous process.
- Document biopsy or pathology results confirming giant cell granuloma — especially multinucleated giant cells — to support the specificity of this code over a general jaw lesion code.
- Note any prior treatment history (corticosteroid injection, calcitonin, denosumab, prior curettage) relevant to recurrence cases.
Related CPT procedures
Procedure codes commonly billed with M27.1. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M27.1 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M27.1 for a peripheral giant cell granuloma (giant cell epulis on the gingiva) — that lesion codes to K06.8, which is a Type 1 Excludes from M27.1 and cannot be coded simultaneously.
- Using a generic jaw or granuloma code (e.g., L92.9 or M27.9) when the pathology report and imaging clearly confirm a central giant cell granuloma — M27.1 is the specific, billable code and should be used.
- Omitting the distinction between 'central' and 'peripheral' in the documentation, forcing the coder to default to an unspecified code when the provider's note would have supported M27.1.
- Applying a 7th-character extension to M27.1 — no 7th character is valid for this M-code.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
Use M27.1 when the diagnosing clinician documents a giant cell granuloma located centrally within the jawbone — most commonly the mandible. The 'central' designation is anatomically precise: the lesion originates inside the cortical bone, not on the gingival surface. If the lesion is peripheral (gingival / giant cell epulis), it is coded to K06.8, which is a Type 1 Excludes from M27.1 — these two codes cannot be used together.
M27.1 covers central giant cell reparative granuloma of the jaw and Giant cell granuloma NOS per the ICD-10-CM Tabular List. This code sits under parent M27 (Other diseases of jaws) in Chapter 13. Though Chapter 13 is the musculoskeletal chapter, this code is routinely billed in oral and maxillofacial surgery, dental oncology, and head-and-neck contexts. It maps to MS-DRG groups 157–159 (Dental and oral diseases) for inpatient encounters.
This code has no laterality subdivision — there is no separate code for mandible vs. maxilla or left vs. right jaw. Document which jaw and which side in the clinical note for surgical planning, but M27.1 is the single billable code regardless of exact intraosseous location. No 7th-character extension applies.
Inclusion & exclusion notes
Per the official ICD-10-CM Tabular List.
Source · CDC ICD-10-CM Official Tabular List · 2026
Includes
- Giant cell granuloma NOS
Excludes 1 — never code together
- peripheral giant cell granuloma (K06.8)
Sibling codes
Other billable codes under M27 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What is the difference between central and peripheral giant cell granuloma for coding purposes?
02Does M27.1 require a laterality modifier or 7th-character extension?
03Which CPT codes are commonly paired with M27.1?
04Can M27.1 be used if a pathology report is pending at the time of billing?
05What MS-DRGs does M27.1 map to for inpatient claims?
06Is M27.1 appropriate for recurrent central giant cell granuloma after prior curettage?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M26-M27/M27-/M27.1
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M27.1
- 04icdlist.comhttps://icdlist.com/icd-10/M27.1
- 05unboundmedicine.comhttps://www.unboundmedicine.com/icd/view/ICD-10-CM/871245/all/M27_1___Giant_cell_granuloma__central
Mira AI Scribe
Mira's AI scribe captures the lesion's intraosseous location (central vs. gingival), the affected jaw and side, imaging characteristics (expansile lucent lesion, cortical involvement, root resorption), and pathology results confirming multinucleated giant cells. Capturing 'central' explicitly prevents downcoding to K06.8 (peripheral) or the unspecified M27.9, which can trigger payer queries and delay authorization for surgical excision.
See how Mira captures M27.1 documentation